A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory light-chain (AL) amyloidosis
Academic Article
Publication Date:
2017
Iris type:
1.1 Articolo in rivista
List of contributors:
Sanchorawala, V; Palladini, Giovanni; Kukreti, V; Zonder, Ja; Cohen, Ad; Seldin, Dc; Dispenzieri, A; Jaccard, A; Schönland, So; Berg, D; Yang, H; Gupta, N; Hui, Am; Comenzo, Rl; Merlini, Giampaolo
Published in: